The question of whether Eurycoma longifolia, commonly known as Tongkat Ali, is subject to prohibition arises due to varying regulatory landscapes across different regions and concerns regarding its composition and potential side effects. This naturally occurring substance, primarily sourced from Southeast Asia, has gained attention for its traditional use in addressing male infertility and enhancing athletic performance. However, inconsistent product quality and the presence of unapproved ingredients contribute significantly to regulatory scrutiny.
The demand for this botanical extract stems from its purported benefits, including increased testosterone levels, improved libido, and reduced stress. Historically, it has been an integral part of traditional medicine practices in countries like Malaysia and Indonesia. Its traditional use has created a market that is vulnerable to adulteration and unscrupulous actors seeking to profit from its popularity, frequently resulting in products that do not meet safety or efficacy standards. These actions impact the continued availability of legitimate, tested products.
